Delivery Order SPE2DX22D0129-SPE2D826F0DND
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $74,615.40 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $33,813.45 by the Defense Logistics Agency Medical Supply Chain on January 16, 2026, with an ultimate completion date of January 20, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This award represents a task order under Amerisourcebergen's larger Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $30,977.72 on January 7, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract has a completion date of January 8, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $527,237.59 on January 31, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is scheduled for completion by February 2, 2026, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $359,118.63 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $33,368.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on January 29, 2026. This firm fixed-price contract, with an ultimate completion date of January 30, 2026, is a non-set-aside award issued through a competitive process. The contractor's place of performance is Conshohocken, Pennsylvania, where the company's corporate office is headquartered. This delivery order operates under...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $45,231.48 by the Defense Logistics Agency's Medical Supply Chain on January 19, 2026. This non-set-aside contract will be performed at the company's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of January 20, 2026. The delivery order represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $214,766.86 by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price contract, which is not set aside for any specific business category, represents a competitive award to the pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The delivery order falls...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a firm fixed-price delivery order valued at $122,350.80 by the Defense Logistics Agency's Medical Supply Chain on January 22, 2026, with an ultimate completion date of January 23, 2026. This non-competitive delivery order, issued under contract number 4570594319, represents a task order against Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through...
- SPE2DX22D0129Indefinite Delivery Contract
- SPE2DX22D0129-SPE2D826F0DNDDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at approximately $15.7K by the Defense Logistics Agency's Medical Supply Chain on February 2, 2026, with an ultimate completion date of February 3, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $1 billion through December 2026), which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp maintains a significant federal contracting presence, consistently delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's competitively awarded contract portfolio demonstrates its capability to efficiently fulfill government procurement requirements for essential pharmaceutical and medical supplies, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 2/1/26 |